Default object view. Click to create a custom template, Node ID: 179611, Object ID: 107391

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicent...

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

No relation

Yes

No relation

No

29/01/2017 3:29 pm

No